- Home
- MRNA vs RBA Comparison
MRNA vs RBA Comparison
Compare MRNA & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- RBA
- Stock Information
- Founded
- MRNA 2010
- RBA 1958
- Country
- MRNA United States
- RBA United States
- Employees
- MRNA N/A
- RBA N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- RBA Business Services
- Sector
- MRNA Health Care
- RBA Consumer Discretionary
- Exchange
- MRNA Nasdaq
- RBA Nasdaq
- Market Cap
- MRNA 10.9B
- RBA 21.4B
- IPO Year
- MRNA 2018
- RBA 1998
- Fundamental
- Price
- MRNA $25.00
- RBA $118.15
- Analyst Decision
- MRNA Hold
- RBA Buy
- Analyst Count
- MRNA 19
- RBA 5
- Target Price
- MRNA $43.50
- RBA $120.40
- AVG Volume (30 Days)
- MRNA 12.2M
- RBA 881.9K
- Earning Date
- MRNA 11-06-2025
- RBA 11-07-2025
- Dividend Yield
- MRNA N/A
- RBA 1.05%
- EPS Growth
- MRNA N/A
- RBA 14.00
- EPS
- MRNA N/A
- RBA 2.03
- Revenue
- MRNA $3,078,000,000.00
- RBA $4,418,000,000.00
- Revenue This Year
- MRNA N/A
- RBA $6.23
- Revenue Next Year
- MRNA $10.17
- RBA $4.88
- P/E Ratio
- MRNA N/A
- RBA $58.13
- Revenue Growth
- MRNA N/A
- RBA 4.66
- 52 Week Low
- MRNA $23.15
- RBA $78.08
- 52 Week High
- MRNA $75.37
- RBA $118.79
- Technical
- Relative Strength Index (RSI)
- MRNA 46.40
- RBA 61.87
- Support Level
- MRNA $23.18
- RBA $116.12
- Resistance Level
- MRNA $25.90
- RBA $118.79
- Average True Range (ATR)
- MRNA 1.18
- RBA 1.74
- MACD
- MRNA 0.18
- RBA -0.00
- Stochastic Oscillator
- MRNA 66.91
- RBA 87.05
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About RBA RB Global Inc.
RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.